Navigation Links
Patient-Specific Stem Cell Therapy to Halt or Reverse the Damage of Parkinson’s Disease Gets Support from National Stem Cell Foundation
Date:4/29/2016

Summit for Stem Cell has received a $250,000 grant from the National Stem Cell Foundation (NSCF) to support the development of a patient-specific stem cell therapy for the treatment of Parkinson’s disease. The Summit research project is directed by Dr. Andrés Bratt-Leal in the lab of Dr. Jeanne Loring at The Scripps Research Institute in San Diego, CA.

The aim of of the research is to use a patient’s own skin cells to create normal dopamine-producing neurons that can be returned to the patient without rejection. Dopamine, a chemical that sends messages to areas of the brain that control movement and coordination, is decreased in Parkinson’s when dopamine-producing neurons malfunction or die. This patient-specific therapy has the potential to halt or reverse the damage of Parkinson’s disease and other neurological disorders, including ALS.

According to Dr. Paula Grisanti, National Stem Cell Foundation Chairman, “As an organization, we are committed to partnering with strong organizations and building consortiums to get great research through the funding “valley of death” that is too often the fate of promising ideas. We are delighted to make this grant for patient-specific stem cell research that will advance treatment options for Parkinson’s and other neurodegenerative diseases.”

Jenifer Raub, Summit’s Board President, says, “The generous support provided by the National Stem Cell Foundation will advance this research at a critical point and move us closer to FDA-approved clinical trials. We are thrilled by this unique partnership with NSCF.”

About Summit for Stem Cell
Summit for Stem Cell is an all-volunteer organization working to fund research that will directly impact treatment options for the debilitating effects of Parkinson's disease. Summit is at the vanguard of a unique collaboration between patients, clinicians, scientists, volunteers, patient advocates and the community-at-large to move innovative research forward in cooperation with The Scripps Research Institute and Scripps Clinic. For more information visit: http://www.SummitforStemCell.org

About National Stem Cell Foundation
The National Stem Cell Foundation is a 501(c)3 non-profit organization funding stem cell and regenerative medicine research and clinical trials in four primary focus areas: Neurodegenerative Disease, Autoimmune Disease, Rare Childhood Disorders and Regenerative Repair. NSCF’s goal is to fund promising developments in the field of regenerative medicine, support research collaboration wherever possible and accelerate access to scientific breakthroughs for people in need. For more information visit: http://www.NationalStemCellFoundation.org

Read the full story at http://www.prweb.com/releases/2016/04/prweb13376046.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. New Hudsonville-Based Biomedical Startup, Imago Prints, Uses Patient-Specific Ultrasound Data to Produce One-of-a-Kind 3D Printed Renderings of Infants During Pregnancy
2. Seamless gene correction of beta-thalassemia mutations in patient-specific cells
3. University Of Colorado Cancer Center Tests Promising New Drug to Treat and Protect Against Radiotherapy-Associated Oral Mucositis
4. Transplanted brain cells in monkeys light up personalized therapy
5. NW Bio To Review Its Leadership Position In Immune Therapy At The 25th Annual Roth Conference
6. SoundMindz TM Releases ‘Anti-Anxiety TM’ Mobile App - A Complete Stress Therapy Program
7. Cellular Therapy and Cord Blood 2013 Market Report
8. Gene therapy may aid failing hearts
9. QVC and Fashion Footwear Association of New York Invest in Personalized Breast Cancer Therapy Research
10. Arctic Animal, Warm Hearts: National Robotics Week Display Features Robot Therapy for Palliative and Dementia Care
11. Gene Therapy Developed for ALS Treatment: New Biotech Company Neuralgene Enters Evaluation Phase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2018)... (PRWEB) , ... September 05, 2018 , ... Now available ... Systems will be held on Sept. 19, 2018. With a panel of industry leaders ... this exciting event will reveal industry insights from experts in the field. Register ...
(Date:9/7/2018)... ... September 06, 2018 , ... Akadeum Life Sciences today announced it ... as an executive and leader of numerous biotech companies. , He most recently ... company acquired by Thompson Street Capital in St. Louis, MO. Prior to ISTO, ...
(Date:8/29/2018)... CARMEL, Ind. (PRWEB) , ... August 28, 2018 ... ... company selling nano-technology enhanced spinal implants, announced today the successful completion of a ... 1st Source Capital Corporation, Purdue’s Foundry Investment Fund, Commenda Capital, and Ellipsis Ventures. ...
(Date:8/29/2018)... Calif. (PRWEB) , ... August 28, 2018 , ... ... scientists from around the world, is proud to announce the launch of a new ... offers for a chance to win one of LabRoots most popular shirts. , Throughout ...
Breaking Biology Technology:
(Date:9/12/2018)... ... 12, 2018 , ... JoVE, the leading producer and publisher ... professional development of academic librarians by sponsoring four award-winners to attend the Charleston ... submit successful strategies to increase collaboration among librarians and STEM faculty and students. ...
(Date:9/7/2018)... ... September 06, 2018 , ... ... AMDA) to purchase its commercial spine business, which includes its complete portfolio of ... the spine that result from it. The deal will make CTL Medical the ...
(Date:8/31/2018)... ... August 30, 2018 , ... In recent years researchers have ... discovery programs. Longer-target engagement can result in improved efficacy and reduced side effects. ... or require the alteration of the molecules involved. The limitations of these methods ...
Breaking Biology News(10 mins):